For many people living with vitiligo, treatment begins with a seemingly simple goal: restoring lost color. Creams, light therapy, and other treatments supervised by dermatologists can help stimulate repigmentation or slow the formation of new patches.
However, there is another side to the therapeutic conversation—one that receives less public attention.
When vitiligo affects a significant part of the body, repeatedly trying to restore pigment may no longer feel like a realistic or personally important goal. Conversely, some adults discuss depigmentation treatment with their dermatologist: the deliberate process of removing remaining natural pigment to create a more even skin tone.
This is a major and generally permanent decision. Therefore, it is important to understand the difference between repigmentation and depigmentation before considering any product or treatment.
Two very different areas of treatment
Vitiligo occurs when pigment-producing cells called melanocytes are damaged or destroyed, causing lighter areas of skin to appear. The size, location and progression of these areas can vary greatly from one person to another.
For a person with multiple localized patches, treatment may be aimed at restoring the pigment. Dermatologists may use topical medications, phototherapy, or other interventions to reverse the discoloration and slow the progression of the condition. The American Academy of Dermatology explains that treatment plans are individualized and can be aimed at restoring color, preventing the expansion of existing patches and reducing the formation of new ones.
Depigmentation therapy moves in the opposite direction. Instead of treating lighter areas, it gradually lightens the remaining pigmented skin so that it better matches areas already affected by vitiligo.
This approach is usually intended for broad situations. The UK’s National Health Service notes that depigmentation may be considered for adults whose vitiligo affects more than half of the body. It is usually not an early treatment or a solution of several isolated patches.
Why might someone consider depigmentation
The decision is very personal.
A person with widespread vitiligo may spend years trying different treatments, covering up contrast patches with makeup, or planning around noticeable changes in skin tone. Even when the condition is medically benign, the daily effort to manage its appearance can be significant.
For some, it’s helpful to keep track of repeats. Others may decide that creating a consistent look is more practical than repeatedly trying to restore color in multiple areas.
None of these choices should be universally correct. An important question is which approach reflects the individual’s diagnosis, treatment history, expectations, and comfort with constant change.
A dermatologist can also determine if the condition is stable, if further recurrence remains possible, and if the depigmentation is medically appropriate.
Monobenzone is not a common skin ingredient
One of the most popular drugs associated with permanent depigmentation is monobenzone, also known as monobenzyl ether hydroquinone or MBEH.
Although its name is sometimes mentioned alongside hydroquinone, the two substances should not be considered interchangeable cosmetic lighteners. Hydroquinone reduces melanin production and is usually associated with the treatment of hyperpigmentation. Monobenzone can destroy melanocytes and can cause permanent loss of pigment.
According to DermNet’s clinical overview of depigmentation treatment, monobenzone is the main depigmentation treatment used for widespread vitiligo and generally causes irreversible depigmentation.
This is permanent precisely because it can never be used to lighten normal pigmented skin, correct tan or treat simple dark spots.
The effect can also extend beyond the exact area where the cream is applied. This product is not intended for testing, informal cosmetic use or self-treatment without a confirmed diagnosis.
Understanding the products that patients are exposed to
People who research depigmentation online may see several different product names, formulations, and concentrations. Common examples include monobenzone creams sold under names such as Benoquin or Benoquik. Some specialty registries also list mequinol, methoxsalen products, and topical treatments used in repeat protocols.
These products may appear together because they are widely related to pigment disorders, but they do not necessarily perform the same function.
Monobenzone is associated with permanent depigmentation. Methoxsalen can be used with controlled UV exposure in the treatment of certain pigmentation. Tacrolimus and other topical medications may be prescribed to stimulate repigmentation or control inflammation. Mequinol has a variety of cosmetic and dermatological applications and should not automatically be considered a substitute for monobenzone.
For readers who have already received professional advice and are comparing existing formulas, Skin depigmentation and vitiligo management products listed by OKDERMO provide an example of the range of monobenzone creams and related pigment management options available through specialist international retailers.
Viewing a directory can help patients understand the brands and strengths available, but it cannot determine which treatment is appropriate. This decision should be based on the dermatologist’s assessment and the legal requirements governing prescription or imported drugs in the patient’s country.
Five questions to discuss before treatment
Is depigmentation really an appropriate goal?
One must be sure that the goal is to remove the remaining pigment – not to restore the lost pigment or just lighten a few darker areas. Mistaking these goals can lead to results that are not easily reversed.
How permanent is the result?
The pigment loss associated with monobenzone is generally considered permanent. Some uneven or partial pigmentation may reappear, but patients should begin treatment with the expectation of a permanent change.
How long can the process take?
Depigmentation is gradual, not immediate. Depending on the area treated and individual response, it may take months to achieve a uniform appearance. Treatment compliance and follow-up are important.
What reactions should be monitored?
Sensation, redness, itching, and contact dermatitis may occur. Any unexpected occurrence of pigment loss, severe inflammation or other reactions should be reported to the prescribing clinician.
How is the skin protected after that?
Melanin provides natural protection against UV radiation. When pigment is reduced, the skin becomes more vulnerable to sunburn and UV damage. Broad sun protection, protective clothing, and a sensible sun diet are part of long-term, not temporary, daily care.
An emotional decision is also important
Clinical compliance is only part of the decision.
Permanent depigmentation can change how a person perceives their appearance and how other people respond to them. Even when the result is medically successful, adjusting to major visual changes can take time.
Some patients find it valuable to talk to a counselor, vitiligo support organization, or other people who have experienced depigmentation. Photos may show the physical results, but they cannot fully convey what it is like to live with the transformation.
Therefore, a reasonable treatment plan should consider emotional readiness as well as medical safety.
A more informed way to heal
Depigmentation treatments should not be marketed as a quick fix to lighter skin. This is a special option for selected adults with extensive vitiligo who have carefully considered the permanence, risks and practical implications.
The most responsible way starts with three steps:
- Confirm the diagnosis and extent of vitiligo with a qualified dermatologist.
- Determine if the goal is permanent repigmentation or depigmentation.
- Before starting, review the drug, concentration, expected schedule, monitoring plan, and sun protection requirements.
For the right patient, depigmentation can offer a sense of visual consistency after years of managing areas of severely contrasting skin. For someone with localized vitiligo, uncertain goals, or normal pigmentation concerns, it may be completely inappropriate.
The value is not only in having access to the product, but in understanding exactly what the product is meant to do and being prepared for the results.
Medical refusal: This article is intended for general educational purposes and is not a substitute for individual medical advice. Depigmentation medications can cause permanent changes and should only be used after evaluation and guidance from a healthcare professional.
Sponsored Content – This content is brought to you by Chris Reyes
- About the Author
- Latest news
Our editorial team are writers and experts in their field. Their views and opinions are not necessarily those of Wellbeing Magazine. If you are under medical supervision, talk to your doctor or therapist before following the advice and recommendations in this article.
